openPR Logo
Press release

Global Epistaxis Market: Size, Trends, Growth & Forecast Report 2017-26

03-26-2018 11:23 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Fact.MR

Fact.MR

Fact.MR

FACT.MR has been actively involved in offering comprehensive research data concerning various topics which are associated to industrial reference and investor utility. This particular research report titled “Epistaxis Market Forecast, Trend Analysis & Competition Tracking – Global Review 2017 to 2026” has been added to the wide online database of FACT.MR which discusses the present as well as future market scenario. Readers can access knowledge related to market volume, regional expanse as well as competitive landscape prevailing in the globalEpistaxis Market. In order to study development patterns, this smart assessment also focuses on market dynamics, which talks about drivers, restraints and opportunities estimated to influence the concerned market during the period until 2022.

Request For Sample Report @ https://www.factmr.com/connectus/sample?flag=S&rep_id=344

Conditions that predispose a person to nosebleeds include dry and less humid weather conditions and increasing prevalence of hypertension. According to World Health Organization (WHO), over 12% of the deaths caused globally are due to hypertension. Incidence of nosebleeds continue to increase with the increasing cases of hypertension. Moreover, prevalence of hypertension in pregnant women leads to increasing blood flow towards the mucous membrane. Such factors continue to rev up demand for the epistaxis products in the global market.

According to Fact.MR, the global epistaxis market is expected to represent a value of nearly US$ 13 Mn by the end of 2026.

Extreme Weather Conditions to Impact Global Market Growth

Epistaxis continues to remain a common health problem observed among the adults and children. Impact of extreme weather conditions can lead to crusting of the mucous secretion processes, which can result into cracks in the nose lining. Extreme dryness and heat in the air can result in dry nasal membrane and eliminates the amount of moisture required to be maintained in the nose. Frequent changes in the environmental conditions such as less humid weather and extremely cold winters lead to increasing instances of dry nasal membrane. Dry nasal membrane leads to increasing occurrences of nosebleeds during the hot, cold and dry weather. Increasing incidences of dry nasal membrane and abnormal nosebleeds is expected to boost demand for epistaxis products during the forecast period.

Key Insights from the Report

The study has analyzed the global epistaxis market on the basis of indication, distribution channel, and product types. Key research findings on the segmental analysis of the global epistaxis market include:

In 2017, more than forty percent of revenues procured in the global epistaxis market will be accounted by the sales of cauterizing agents
Through 2026, global sales of cauterizing agents for epistaxis treatment are estimated to bring in nearly US$ 90 Mn
Hospitals will represent the largest distribution channel for epistaxis drugs, accounting for more than one-third share of global revenues during the forecast period
A majority of products sold in the global epistaxis market will be used in treatment of anterior epistaxis, revenues from which are estimated to be worth over US$ 200 Mn by 2026-end
Anterior Indication to Represent a Leading Segment

With the growing incidences of nose cauterization among the children and adults has led to surge in demand for cauterization agents in the global market. On the basis of product type, the cauterization agents segment is expected to represent the highest revenue growth, accounting for a value of over US$ 30 Mn by the end of 2026. On the other hand, the antibiotic ointment product type segment is expected to register a significant CAGR during the forecast period.

Based on distribution channel, the retail pharmacies segment is expected to generate significant revenues, accounting for a value of nearly US$ 20 Mn by the end of 2017. However, the specialty clinics distribution channel segment is expected to register a robust CAGR through 2026.

By indication, the anterior segment is expected to represent a robust revenue growth, recording a value of nearly US$ 80 Mn by the end of 2026. In contrary, the posterior indication segment is expected to register a healthy CAGR throughout the forecast period.

Competition Tracking

Leading market players operating on the global epistaxis market include Bristol-Myers Squibb Company, Ciron Drugs & Pharmaceuticals Pvt. Ltd., Pfizer Inc., Medline Industries, Inc., Smith & Nephew, GlaxoSmithKline PLC and Ferring B.V.

Browse Full Report with TOC @https://www.factmr.com/report/344/epistaxis-market

Table Of Content

Chapter 1 Global Outlook

Chapter 2 Global Epistaxis Market - Executive Summary

Chapter 3 Global Epistaxis Market Overview
3.1 Introduction
3.1.1 Global Epistaxis Market Taxonomy
3.1.2 Global Epistaxis Market Definition
3.2 Global Epistaxis Market Size (US$ Mn) and Forecast, 2012-2026
3.2.1 Global Epistaxis Market Y-o-Y Growth
3.3 Global Epistaxis Market Dynamics
3.4 Supply Chain
3.5 Cost Structure
3.6 Epistaxis Epidemiology
3.7 Key Regulations
3.8 Patent Analysis
3.9 PESTL Analysis
3.10 Product Lifecycle
3.11 Pricing Analysis
3.12 Service Provider List
3.13 Key Participants Market Presence (Intensity Map) By Region

Continue…@@

Check Discount @ https://www.factmr.com/connectus/sample?flag=D&rep_id=344

About Fact.MR

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized Healthcare Marketresearch reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us

Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Epistaxis Market: Size, Trends, Growth & Forecast Report 2017-26 here

News-ID: 991927 • Views:

More Releases from Fact.MR

Bioinformatics Market is Growing at a CAGR of 13.4% by 2034 | Fact.MR Report
Bioinformatics Market is Growing at a CAGR of 13.4% by 2034 | Fact.MR Report
The latest report on the Bioinformatics Market, projecting robust growth driven by the increasing demand for genomic research, advancements in artificial intelligence (AI), and the rising adoption of precision medicine. Valued at USD 14.29 billion in 2024, the global market is forecast to expand at a compound annual growth rate (CAGR) of 13.4%, reaching USD 50.25 billion by 2034. This significant growth underscores the critical role of bioinformatics in decoding
Residential Robotic Vacuum Cleaner Market to Reach USD 11.6 Billion by 2033 | Key Players: iRobot Corporation, Neato Robotics, Inc., Yujin Robot, Co., Ltd., and Dyson Inc
Residential Robotic Vacuum Cleaner Market to Reach USD 11.6 Billion by 2033 | Ke …
Fact.MR today released its latest report on the Residential Robotic Vacuum Cleaner Market, projecting robust growth driven by increasing demand for automation, busy lifestyles, and advancements in smart home technologies. Valued at USD 3.0 billion in 2023, the global market is forecast to expand at a compound annual growth rate (CAGR) of 14.4%, reaching USD 11.6 billion by 2033. This significant growth highlights the rising adoption of robotic vacuum cleaners
Brain-Computer Interface Market is Estimated to Reach USD 6.5 Billion by 2033
08-29-2025 | Health & Medicine
Fact.MR
Brain-Computer Interface Market is Estimated to Reach USD 6.5 Billion by 2033
The global brain-computer interface (BCI) market was valued at USD 1.6 billion in 2022 and is projected to reach USD 6.5 billion by 2033, growing at a compound annual growth rate (CAGR) of 13.6% from 2023 to 2033. This expansion reflects the increasing adoption of BCI technologies in medical applications, driven by advancements in neuroscience, AI, and sensor technologies. BCIs enable direct communication between the brain and external devices, offering
Orally Disintegrating Tablet Market is Projected to Reach USD 72.68 Billion by 2034 | Key Players: Johnson & Johnson Services Inc; Teva Pharmaceutical Industries Ltd.; Sun Pharmaceutical Industries Ltd.; Takeda Pharmaceutical Company Limited
08-29-2025 | Health & Medicine
Fact.MR
Orally Disintegrating Tablet Market is Projected to Reach USD 72.68 Billion by 2 …
The global orally disintegrating tablet (ODT) market is valued at USD 24.45 billion in 2024 and is forecasted to expand at a compound annual growth rate (CAGR) of 11.5%, reaching USD 72.68 billion by 2034. This robust growth is driven by the increasing demand for patient-friendly dosage forms, particularly among the elderly, pediatric, and dysphagic populations, who benefit from ODTs' ease of administration without water and rapid dissolution. ODTs enhance

All 5 Releases


More Releases for Epistaxis

Epistaxis Drugs Market Size and Forecast
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- The global Epistaxis Drugs Market is expected to record a CAGR of XX.X% from 2024 to 2031 In 2024, the market size is projected to reach a valuation of USD XX.X Billion. By 2031 the valuation is anticipated to reach USD XX.X Billion. The impact of manufacturers on the market is significant across various industries, influencing supply chains, consumer choices, and economic growth. Manufacturers are key players in
Epistaxis Device market foreseen to grow exponentially over 2017-2026
According to Stratistics MRC, the Global Epistaxis Device market is accounted for $17,848.91 thousands in 2017 and is expected to reach $34,508.19 thousands by 2026 growing at a CAGR of 7.6% during the forecast period. Some of the key factors such as increasing incidences of the dry nasal membrane and abnormal nosebleeds are expected to boost demand for the market. Moreover, the side effects such as pain, swelling and running
Epistaxis Market UpComing Developments With Major Key Players
The global epistaxis market was valued at US$ 130.0 million in 2016 and is expected to witness a CAGR of 5.7% during the forecast period (2017 – 2025). Rising cases of cardiovascular disorders, mainly hypertensive diseases, which are highly susceptible to hemorrhage are the leading causes of epistaxis. According to the Medical Statistics of World Health Organization in 2015, there were approximately 289,000 cases of hypertension recorded among pregnant women. According
Epistaxis Market to Witness an Outstanding Growth by 2026
Growing prevalence of hypertension is expected to impact the global epistaxis market. Instances of dry mucous membrane attributed to extreme weather conditions will continue to rev up demand for epistaxis products globally. This Market Research report analyzes the expansion of global epistaxis market till date, and provides key insights on the growth of the market during the forecast period, 2017-2026. Download Sample Copy of this report @ https://www.xploremr.com/connectus/sample/1819 Scope The scope of Market
09-03-2018 | Health & Medicine
Fact.MR
Epistaxis Market Research Report: Examined by Size, Trends, Share and Leading Su …
Growing prevalence of hypertension is expected to impact the global epistaxis market. Instances of dry mucous membrane attributed to extreme weather conditions will continue to rev up demand for epistaxis products globally. This FactMR report analyzes the expansion of global epistaxis market till date, and provides key insights on the growth of the market during the forecast period, 2017-2026. The scope of FactMR’s report is to analyze the global Epistaxis
Epistaxis Market Industry Forecast till 2025
Epistaxis, also known as nosebleed, occurs due to rupturing of a small blood vessel in the lining of nose, as the interior of the nose is highly delicate and sensitive and could not tolerate certain factors that make them fragile and prone to burst resulting in bleeding. Nosebleeds are common mostly during winter, as more of the upper respiratory infections occur during this season. Request Sample Copy of this Business Report